QNASL is a Nasal Aerosol, Metered in the Human Prescription Drug category. It is labeled and distributed by Teva Respiratory, Llc. The primary component is Beclomethasone Dipropionate.
Product ID | 59310-206_357352cc-327d-4c62-a4d6-e60a0748bed4 |
NDC | 59310-206 |
Product Type | Human Prescription Drug |
Proprietary Name | QNASL |
Generic Name | Beclomethasone Dipropionate |
Dosage Form | Aerosol, Metered |
Route of Administration | NASAL |
Marketing Start Date | 2015-02-01 |
Marketing Category | NDA / NDA |
Application Number | NDA202813 |
Labeler Name | Teva Respiratory, LLC |
Substance Name | BECLOMETHASONE DIPROPIONATE |
Active Ingredient Strength | 40 ug/1 |
Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2015-02-02 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA202813 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2015-02-01 |
Marketing End Date | 2019-01-22 |
Marketing Category | NDA |
Application Number | NDA202813 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2015-02-01 |
Marketing End Date | 2015-02-01 |
Marketing Category | NDA |
Application Number | NDA202813 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2015-02-01 |
Marketing End Date | 2015-02-01 |
Marketing Category | NDA |
Application Number | NDA202813 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | GM |
Marketing Start Date | 2015-02-02 |
Marketing End Date | 2019-10-17 |
Ingredient | Strength |
---|---|
BECLOMETHASONE DIPROPIONATE | 40 ug/1 |
SPL SET ID: | 3be74938-3281-4586-a57c-2501e8a06960 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
59310-206 | QNASL | Beclomethasone Dipropionate |
59310-210 | QNASL | Beclomethasone Dipropionate |
59310-406 | QNASL | Beclomethasone Dipropionate |
59310-410 | QNASL | Beclomethasone dipropionate |
50090-1342 | QVAR | Beclomethasone Dipropionate |
50090-3033 | QVAR | Beclomethasone Dipropionate |
59310-202 | QVAR | Beclomethasone Dipropionate |
59310-204 | QVAR | Beclomethasone Dipropionate |
68071-1691 | QVAR | Beclomethasone Dipropionate |
68788-7025 | QVAR | beclomethasone dipropionate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
QNASL 97041779 not registered Live/Pending |
TEVA PHARMACEUTICALS USA, Inc. 2021-09-23 |
QNASL 97041776 not registered Live/Pending |
TEVA PHARMACEUTICALS USA, Inc. 2021-09-23 |
QNASL 85621560 4210215 Live/Registered |
TEVA RESPIRATORY, LLC 2012-05-10 |
QNASL 85621557 4210214 Live/Registered |
TEVA RESPIRATORY, LLC 2012-05-10 |
QNASL 85404349 not registered Dead/Abandoned |
TEVA RESPIRATORY, LLC 2011-08-23 |
QNASL 85404341 not registered Dead/Abandoned |
TEVA RESPIRATORY, LLC 2011-08-23 |
QNASL 85308405 4172769 Live/Registered |
TEVA RESPIRATORY, LLC 2011-04-29 |